Theon International (Euronext: THEON) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR ...

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in a global Phase 3 trial for Stargardt ...

On this "Face the Nation with Margaret Brennan" broadcast, Rep. Mike Turner and Sen. Tim Kaine join Nancy Cordes.